Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (TSXV: $WMD.V) (OTC: $SING) (CSE: $MYM.C) (CSE: $BILZ.C) (TSXV: $FAF.V) (NASDAQ: $OPNT) (NYSE: $SNY)
Delta, Kelowna, BC –July 23, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/07231WMD-SING-MYM-BILZ-FAF-ONPT-SNY.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) announced that it has launched CX Industries Inc., a wholly-owned subsidiary that will specialize in extraction, toll processing and third-party product formulation from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have the capacity to process more than 200,000 kgs of biomass at its peak production in 2020.
“The launch of CX Industries represents the next step in the evolution of WeedMD. The marriage of consistent low-cost input material from our cultivation platform with our fully-licensed extraction hub in Aylmer truly sets us apart. Our management team is now working with strategic partners to provide a platform for entrepreneurs and seasoned brands to enter the concentrates market, building on our history of collaborating successfully with our peers in the cannabis industry,” said Keith Merker, CEO of WeedMD. “We have a solid reputation for executing on our production platforms – rooted in our integrity and transparency, combined with our ability to scale. CX offers world-class extraction and end-to-end production solutions as the market readies for the launch of extracts later this year.”
The Company recently announced the transition of its Aylmer, Ontario facility, now CX Industries, into a large-scale cannabis extraction and processing hub. Together with its greenhouse cultivation and outdoor grow that is in full operation at its Strathroy facility, WeedMD is producing significant low-cost biomass input for extraction.
SinglePoint Inc. (OTCQB: SING) announced that Direct Solar has surpassed everyone’s expectations signing contracts to deploy $1,709,852 in solar installs over the past 30 days. Bringing the two month totals to $3,419,312 in contracts, $1,687,886 in revenue and $757,700 in net. Now that these are in contract they will move to the next phase in planning and installation. Most of the revenue derived from these contracts will be recognized throughout the third and fourth quarter. The previous 30 days should generate approximately $884,117 in gross and $396,159 in net.
Currently Direct Solar is operational in 8 states and continues to expand its residential solar footprint. As the company has solidified itself and proven the model, many financing companies have approached the company to start a commercial financing division. The first financing contract was signed last week and now the company will offer renewable energy options to commercial operations and have the ability to finance these larger scale projects. This additional market opens up a tremendous amount of opportunity in a currently underserved market.
As solar continues to gain traction and renewable energy becomes a top of mind conversation for many people, studies continue to pile up. Most recently, CITE research in a nationally representative poll found that 70% of people said they would support of version a California’s solar mandate. This is not far off from the 2016 Pew Research study that found 89% of Americans supported expanding rooftop solar.
In addition, according to Zion Market Research, the global Solar Panel Market accounted for USD $30.8 Billion in 2016 and is expected to reach USD $57.3 billion by 2022 growing at a CAGR of 10.9% between 2017 and 2022.
MYM Nutraceuticals Inc. (CSE: MYM) (OTCBB: MYMMF) announced that its joint venture company (MYM owns 50%), BioHemp Naturals Growing & Farming Ltd. ("BioHemp"), has signed a non-binding Letter of Intent ("LOI") for the sale of $25 million of CBD-rich hemp biomass.
"I am truly excited to share that our sales team has secured a LOI for $25 million, representing nearly half of our remaining forecasted CBD-rich hemp biomass," said Howard Steinberg, CEO of MYM. "The recipient of the biomass represents a consortium of Canada's largest cannabis LP's and is a great vote of confidence to the quality of BioHemp's Canadian grown CBD-rich hemp."
Fire & Flower Holdings Corp. and its wholly-owned subsidiary Fire & Flower Inc. (TSXV: FAF), today announced that it has received its licence to operate a cannabis retail store in Whitehorse, Yukon from the Yukon Liquor Corporation, Cannabis Licensing.
Upon opening, this will be the 24th Fire & Flower branded, licensed cannabis store and will be located at #110, 80 Chilkoot Way, Whitehorse, Yukon.
In addition to continuing to deliver on Fire & Flower's rapid near-term rollout schedule, the receipt of a licence in the Yukon territory demonstrates Fire & Flower's ability to successfully open cannabis retail stores in provinces across Canada where private cannabis retail is permitted.
"The receipt of a cannabis retail store licence in the Yukon demonstrates Fire & Flower's ability to successfully open retail stores rapidly across multiple jurisdictions with varying regulatory requirements," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "The opening of a Fire & Flower store in this northern Canadian market will enable us to further understand cannabis purchasing preferences through our proprietary Hifyre digital platform, that in turn will allow us to better tailor our experience to local markets. We look forward to becoming members of the Whitehorse community and welcoming local customers into our store."
Fire & Flower will announce the opening date and time of the Whitehorse store at its earliest opportunity on its website at www.fireandflower.com/locations/.
Ignite International, Ltd., a wholly owned subsidiary of Ignite International Brands, Ltd. (CSE:BILZ), today announced that it has signed a joint venture agreement with Grupo Ensejal, S.A. de C.V. The joint venture, which will operate as a newly formed legal entity, will encompass convenience, specialty retail, pharmacy and e-commerce retail channels.
"Ignite is quickly becoming a global powerhouse brand and expanding to our neighbors to the south was a natural next step. The creation of the Mexican joint venture gives Ignite first mover positioning in Mexico to build relationships and trust with retailers and buyers," said Jim McCormick, President of Ignite International Brands, Ltd., "Grupo Ensejal is the perfect partner for us as they get the power of Dan Bilzerian's global reach and understand the power of smart marketing when creating brands."
The joint venture will draw on Ignite's marketing expertise and the brand recognition of the Ignite trademark, the iconic goat's skull logo and founder Dan Bilzerian who has amassed a global social media fan base of over 44 million followers across the leading social media platforms.
Added Roberto Celaya Burruel, Partner of Grupo Ensejal, "We are excited to be a part of the rapid expansion of the Ignite brand and bringing it to Mexico. We have been watching what Dan Bilzerian has been doing with Ignite over the past year in the United States and we are confident we can continue the buzz for our neighbors to the north."
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that it has signed an agreement with Sanofi (NYSE:SNY) to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute Cannabinoid Overdose (ACO). Opiant intends to reformulate drinabant, a high affinity, selective cannabinoid receptor antagonist, for parenteral administration in an emergency department setting. Opiant licensed exclusive global rights from Sanofi for the development and commercialization of drinabant for the emergency treatment of ACO. The manufacturing will be performed in Sanofi Újpest site (Hungary) acting as a Contract Development and Manufacturing Organization (CDMO).
“This agreement marks an important milestone in our partnership with Sanofi and the OPNT004 development program and supply chain,” said Roger Crystal, M.D., Chief Executive Officer of Opiant. “This further enhances our position as a leader in developing medicines for the treatment of addiction and drug overdose.”
ACO is most often linked to the ingestion of both “edibles”, products containing large quantities of D9-tetrahydrocannabinol (THC) that are often sold as brownies, cookies, and candies, and synthetic cannabinoids (sold with names such as “K2” and “Spice”) that are more potent, easily obtained, and less expensive than cannabis containing products. It is estimated that ACO resulted in more than one million emergency department visits in the United States in 2016, and is expected to rise with increasing legalization of cannabis in North America. Features of ACO can include psychosis, hallucinations, nausea and vomiting, as well as feelings of paranoia, agitation, panic and anxiety. These symptoms often require emergency medical attention and can take from hours to days to fully resolve. There are currently no approved treatments for ACO.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment